Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation

about

Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.Modification of the method to establish a hepatic VX2 carcinoma model in rabbits.

P2860

Q41471591-DB6F8947-6F06-40C5-9360-A819762C4DD0 Q51733150-E5B42C28-5159-4AF5-B504-4AE8C514280B

P2860

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation

Item

http://www.wikidata.org/entity/Q36603626

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Octreotide and celecoxib syner ...... catheter arterial embolisation

@ast

Octreotide and celecoxib syner ...... catheter arterial embolisation

@en

type

Item

label

Octreotide and celecoxib syner ...... catheter arterial embolisation

@ast

Octreotide and celecoxib syner ...... catheter arterial embolisation

@en

prefLabel

Octreotide and celecoxib syner ...... catheter arterial embolisation

@ast

Octreotide and celecoxib syner ...... catheter arterial embolisation

@en

P1476

Octreotide and celecoxib syner ...... catheter arterial embolisation

@en

P2093

Cheng-Wei Tang

http://www.w3.org/2001/XMLSchema#string

Chun-LE Zhang

http://www.w3.org/2001/XMLSchema#string

Huan Tong

http://www.w3.org/2001/XMLSchema#string

Jin-Hang Gao

http://www.w3.org/2001/XMLSchema#string

Shi-Lei Wen

http://www.w3.org/2001/XMLSchema#string

Xiao Li

http://www.w3.org/2001/XMLSchema#string

Zhi-Yin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Cell density regulates prolyl 4-hydroxylase activity independent of mRNA levels.

Regulatory peptide receptors in human hepatocellular carcinomas.

Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study.

Cyclooxygenase-2 in hepatocellular carcinoma.

Cyclooxygenase-2 (COX-2)--a therapeutic target in liver cancer?

Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma.

Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.

Histologic prognostic indicators in hepatocellular carcinoma.

Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.

SOM230 combined with celecoxib prolongs the survival in nude mice with HepG-2 xenografts.

P304

777-782

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2013.897

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235604049

http://www.w3.org/2001/XMLSchema#string

P698

23403801

http://www.w3.org/2001/XMLSchema#string

P932

3570131

http://www.w3.org/2001/XMLSchema#string

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation

about

P2860

P2860

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932